Index Disclaimer

Investing involves risk, including possible loss of principal. Investment in emerging market countries may involve heightened risks such as increased volatility and lower trading volume, and may be subject to a greater risk of loss than investment in a developed country. Please carefully consider the Fund's investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the relevant Fund's prospectus. Please read the prospectus carefully before investing. ChinaAMC Funds are not sponsored, endorsed, issued, sold or promoted by their index providers (only applicable to ETFs and index funds). For details of an index provider including any disclaimer, please refer to the relevant ChinaAMC Fund offering documents.

Source: Fund performance and index data are provided by ChinaAMC and the relevant index providers (if applicable) respectively. This website is prepared by China Asset Management (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission.

Hang Seng Index Disclaimer

The mark and name Hang Seng Hong Kong-Listed Biotech Index, Hang Seng TECH Index and Hang Seng Stock Connect Hong Kong SmallCap Index are proprietary to Hang Seng Data Services Limited (“HSDS”) which has licensed its compilation and publication to Hang Seng Indexes Company Limited (“HSIL”). HSIL and HSDS have agreed to the use of, and reference to Hang Seng Hong Kong-Listed Biotech Index, Hang Seng TECH Index and Hang Seng Stock Connect Hong Kong SmallCap Index by China Asset Management (Hong Kong) Limited (“the Issuer”) in connection with the ChinaAMC Hong Kong Biotech Index ETF, ChinaAMC Hang Seng TECH Index ETF and ChinaAMC Hang Seng Stock Connect Hong Kong SmallCap Index ETF (the “Product”). However, neither HSIL nor HSDS warrants, represents or guarantees to any person the accuracy or completeness of the Hang Seng Hong Kong-Listed Biotech Index, Hang Seng TECH Index and Hang Seng Stock Connect Hong Kong SmallCap Index, its computation or any information related thereto and no warranty, representation or guarantee of any kind whatsoever relating to the Hang Seng Hong Kong-Listed Biotech Index, Hang Seng TECH Index and Hang Seng Stock Connect Hong Kong SmallCap Index are given or may be implied. Neither HSIL nor HSDS accepts any responsibility or liability for any economic or other loss which may be directly or indirectly sustained by any person as a result of or in connection with the use of and/or reference to the Hang Seng Hong Kong-Listed Biotech Index, Hang Seng TECH Index and Hang Seng Stock Connect Hong Kong SmallCap Index by the Issuer in connection with the Product, or any inaccuracies, omissions or errors of HSIL in computing the Hang Seng Hong Kong-Listed Biotech Index, Hang Seng TECH Index and Hang Seng Stock Connect Hong Kong SmallCap Index. Any person dealing with the Product shall place no reliance whatsoever on HSIL and/or HSDS nor bring any claims or legal proceedings against HSIL and/or HSDS in any manner whatsoever. For the avoidance of doubt, this disclaimer does not create any contractual or quasi-contractual relationship between any broker or other person dealing with the Product and HSIL and/or HSDS and must not be construed to have created such relationship.

NASDAQ 100 Index Disclaimer

The Product(s) is not sponsored, endorsed, sold or promoted by NASDAQ, Inc. or its affiliates (NASDAQ, Inc. with its affiliates, is referred to as “NASDAQ”). NASDAQ has not passed on the legality or suitability of, or the accuracy or adequacy of descriptions and disclosures relating to, the Product. NASDAQ makes no representation or warranty, express or implied, to the owners of shares of the Product or any member of the public regarding the advisability of investing in securities generally or in the Product particularly or the ability of the Index to track general stock market performance. NASDAQ's only relationship to the Product and China Asset Management (Hong Kong) Limited (“ChinaAMC”) is in the licensing of certain trademarks and trade names of NASDAQ and of the Index which is determined, composed and calculated by NASDAQ without regard to ChinaAMC or the Product. NASDAQ QMX has no obligation to take the needs of ChinaAMC or its affiliates or the owners of shares of the Product into consideration in determining, composing or calculating the Index. NASDAQ is not responsible for and has not participated in the determination of the prices and amount of shares of the Product, or the timing of the issuance or sale of such shares or in the determination or calculation of the equation by which shares of the Product are to be converted into cash. NASDAQ has no obligation or liability in connection with the administration, marketing or trading of the Product.

NASDAQ does not guarantee the accuracy and/or uninterrupted calculation of the index or any data included therein. Nasdaq makes no warranty, express or implied, as to results to be obtained by the trust on behalf of the product as licensee, licensee's customers and counterparties, owners of the shares of the product, or any other person or entity from the use of the subject index or any data included therein in connection with the rights licensed as described herein or for any other use. NASDAQ makes no express or implied warranties and hereby expressly disclaims all warranties of merchantability or fitness for a particular purpose or use with respect to the index or any data included therein. Without limiting any of the foregoing, in no event shall NASDAQ have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.

CSI Index Disclaimer

All rights in the CSI 300 Index (“Index”) vest in China Securities Index Company (“CSI”). “CSI 300®” is a trade mark of CSI. CSI does not make any warranties, express or implied, regarding the accuracy or completeness of any data related to the Index. CSI is not liable to any person for any error of the Index (whether due to negligence or otherwise), nor shall it be under any obligation to advise any person of any error therein. The Fund based on the Index is in no way sponsored, endorsed, sold or promoted by CSI and CSI shall not have any liability with respect thereto.

Bloomberg Barclays China Treasury + Policy Bank Bond Index Disclaimer

BLOOMBERG® is a trademark and service mark of Bloomberg Finance L.P. and its affiliates (collectively “Bloomberg”). BARCLAYS® is a trademark and service mark of Barclays Bank Plc (collectively with its affiliates, “Barclays”), used under license. Bloomberg or Bloomberg's licensors, including Barclays, own all proprietary rights in the Bloomberg Barclays Indices. Neither Bloomberg nor Barclays is affiliated with China Asset Management (Hong Kong) Limited, and neither approves, endorses, reviews or recommends ChinaAMC Bloomberg Barclays China Treasury + Policy Bank Bond Index ETF. Neither Bloomberg nor Barclays guarantees the timeliness, accurateness or completeness of any data or information relating to Bloomberg Barclays China Treasury + Policy Bank Index, and neither shall be liable in any way to the China Asset Management(Hong Kong) Limited, investors in ChinaAMC Bloomberg Barclays China Treasury + Policy Bank Bond Index ETF or other third parties in respect of the use or accuracy of the Bloomberg Barclays China Treasury + Policy Bank Index or any data included therein.

MSCI Index Disclaimer

The funds or securities referred to herein are not sponsored, endorsed, or promoted by MSCI, and MSCI bears no liability with respect to any such funds or securities or any index on which such funds or securities are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with China Asset Management (Hong Kong) Limited and any related funds.

免責聲明

本網站的資料乃由華夏基金(香港)有限公司(簡稱「華夏(香港)」)編制,僅供參閱用途。本網站有關基金的內容不適用於在限制該內容之發佈的區域居住之人士。就任何不獲授權進行分銷或要約的任何司法管轄區,本網站所載資料並不構成任何證券的分銷,買賣的要約,或促使買賣的要約。

本網站所載之基金(簡稱「基金」)已獲證監會認可向香港公眾人士全面銷售;其所載之任何內容亦未經證監會審閱。

本網站所提及的任何內容均不構成對基金的任何股份的投資邀約,也不構成對於任何證券的買賣或進行任何交易的投資建議。在使用本網站所載資料以前,閣下須根據個人狀況,確定任何投資,證券或策略是否合適閣下;如有須要,應諮詢獨立專業意見。

投資涉及風險,基金單位價格可升亦可跌,基金過往業績並不表示將來的回報。基金的價值可能會非常波動,並可能於短時間內大幅下跌,閣下亦可能損失全數投資金額。投資者應參閱有關基金之配售備忘錄,以了解基金詳情及風險因素,特別是投資於中國市場所涉及之風險。本基金可投資於洐生工具或結構性產品;該等投資工具可涉及重大風險,例如交易對手違約風險,有可能引致基金蒙受嚴重損失。

華夏(香港)已盡其所知使本網站所載資料在發佈之時準確 ;但華夏(香港)並不保證有關資料的準確性及完備性。華夏(香港),其聯營公司,董事,高級職員及僱員對此網站所提供的資料的任何相關錯誤或遺漏並不負責。華夏(香港)亦對於因使用此網站內容而引致或引發的任何損失或代價不承擔責任。

與本網頁所載資料有關的所有版權,專利權及其他產權均為華夏(香港)或其聯屬公司所有。在未經華夏(香港)同意下,不得複印,分發或複製本網頁內之任何資料或任何部分。

Product Risk Warning:

Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in below products, investor should refer to the Fund's prospectus for details, including the risk factors. You should not make investment decision based on the information on this material alone. Please note:


Important Information about ChinaAMC NASDAQ 100 ETF
  • The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ-100 Index. The Fund concentrates its investment in securities listed on the NASDAQ Stock Market and is subject to concentration risk as a result of tracking the performance of markets in a single country (the US) and securities listed on a single exchange (the NASDAQ Stock Market). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in the US. The value of securities in the Fund’s portfolio may change on days when investors will not be able to purchase or sell units of the Fund as the NASDAQ Stock Market will be open when units of the Fund are not priced.
  • The units of the Fund may trade at a substantial premium or discount to their NAV.
  • The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.
  • The Fund's Base Currency is in HKD but has units traded in USD (in addition to HKD). Investors may be subject to additional costs or losses associated with foreign currency fluctuations between the Base Currency and the USD trading currency when trading units in the secondary market.
  • If there is a suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services provided by brokers and CCASS participants, unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing.
  • The market price of units traded in each counter may deviate significantly due to different factors such as market liquidity, market supply and demand in each counter and the exchange rate fluctuations between HKD and USD.

Important Information about ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product / ChinaAMC Nasdaq-100 Index Daily (-1x) Inverse Product / ChinaAMC Nasdaq-100 Index Daily (-2x) Inverse Product:
  • ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product / ChinaAMC Nasdaq-100 Index Daily (-1x) Inverse Product/ChinaAMC Nasdaq-100 Index Daily (-2x) Inverse Product (collectively, “Products”) are futures-based leveraged/inverse products and are not suitable for all investors. The Products only target sophisticated trading-oriented investors who understand the potential consequences of seeking daily leveraged/inverse results and the associated risks and constantly monitor the performance of their holdings on a daily basis.
  • The Products invest directly in E-mini NASDAQ 100 Futures (“Nasdaq-100 Futures”) which are traded on the Chicago Mercantile Exchange (the “CME”). The Products aim to provide daily investment results, before fees and expenses, which closely correspond to leveraged (2x) / inverse (-1x) / inverse (-2x) of the daily performance of the Nadsaq-100 Index (the “Nasdaq-100 Index”).
  • The Products do not seek to achieve their stated investment objectives over a period of time greater than one day.
  • The Products are not intended for holding longer than one day as the performance of the Products over a longer period may deviate from and be uncorrelated to the leveraged/inverse performance of the Nasdaq-100 Index over the period (e.g. the loss may be more than 2 times the decrease in the Index/-1 time the increase in the Index /-2 times the increase in the Index). The Products are designed to be used for short term trading or hedging purposes, and are not intended for long term investment.
  • Investing in the leveraged product is subject to the general market risk of equity investment, its value will be fluctuated because of multiple factors, and both gains and losses will be magnified. Investing in the inverse products is different from taking a short position. Because of rebalancing, the return profile of an inverse product is not the same as that of a short position. Risk investment outcomes of the inverse products are the opposite of conventional investment funds. If the value of the Index increases for extended periods, the inverse product will likely lose most or all of their values.
  • The Products involve futures contracts risk, leveraged/inverse performance risk, risk of rebalancing activities, volatility risk, liquidity risk, intraday investment risk, portfolio turnover risk, concentration risk, US markets risk, Nasdaq-100 constituents risk, passive investment risk, reliance on the investment adviser risk, difference in price limit risk, trading time differences risk, trading risk, reliance on market maker risk, tracking error and correlation risk, termination risk, other currency distributions risk and currency risk.
  • The Products are traded on SEHK, and there are trading time differences between SEHK, CME (where the Futures are traded) and the NASDAQ (where constituents of the Index are traded). The premium/discount of the unit prices of the Products to their NAVs may increase, and there may be imperfect correlation between the value of the index constituents and the Nasdaq-100 Futures, which may adversely affect the Products from tracking the leveraged (2x)/inverse (-1x)/inverse (-2x) daily performance of the Nasdaq-100 Index.

Important Information about ChinaAMC Hang Seng Hong Kong Biotech Index ETF
  • The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng Hong Kong-Listed Biotech Index (the "Index").
  • The Fund is passively managed and the Manager will not have the discretion to adapt to market changes. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
  • The Fund’s investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
  • The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
  • The Fund is subject to concentration risks in biotech companies and in a particular geographical region (i.e., Hong Kong and mainland China). The Fund may be more volatile than a broadly-based fund.
  • The Fund is exposed to risks associated with characters of biotech companies, such as pre-revenue, incurrence of net current liabilities, lower liquidity, higher volatility, dependency on intellectual property rights or patents, technological changes, increased regulations and intense competition.
  • The Fund is subject to tracking error risk.
  • If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
  • Unitholders will receive distributions in the HKD only. In the event that a unitholder has no HKD account, the unitholder may have to bear bank or financial institution fees and charges associated with currency conversion.
  • The Fund's base currency is HKD but has units traded in USD. Investors may be subject to additional costs or losses associated with foreign currency fluctuations.
  • Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC Hang Seng TECH Index ETF
  • The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng TECH Index (the "Index").
  • The Fund is passively managed and the Manager will not have the discretion to adapt to market changes. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
  • The Fund's investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
  • The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
  • The Fund is subject to concentration risks in companies with technology theme and in a single geographical region (i.e., Greater China). The Fund may be more volatile than a broadly-based fund.
  • Companies in the technology sector are characterised by relatively higher volatility in price performance when compared to other sectors.
  • The Fund may be exposed to risks associated with different technology sectors and themes. A downturn in the business for companies in these sectors or themes may have adverse effects on the Fund.
  • The Fund is subject to tracking error risk, which may result from the investment strategy used, and fees and expenses.
  • If there is a suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants, Unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing. The market price of units traded in each counter may deviate significantly.
  • Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC CSI 300 Index ETF
  • The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the CSI 300 Index (the "Index"). The Fund invests in the PRC's securities market through the RQFII investment quota granted to the Manager and the Stock Connect.
  • The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (the PRC) and may likely be more volatile than a broad-based fund.
  • The Fund is subject to risks relating to the RQFII regime, such as default in execution or settlement of transaction by a PRC broker or the PRC Custodian, change of RQFII policy and rules and uncertainty to their implementation, repatriation restrictions and insufficient RQFII quota to the Fund.
  • The Fund is subject to risks associated with the Stock Connect, such as change of relevant rules and regulations, quota limitations, suspension of the Stock Connect programme. In the event that the Fund’s ability to invest in A-Shares through the Stock Connect on a timely basis is adversely affected, the Manager can only rely on RQFII investments to achieve the Fund’s investment objective.
  • Investing in emerging markets, such as the PRC, involves a greater risk such as greater political, tax, economic, foreign exchange, liquidity and regulatory risks.
  • If there is a suspension of the inter-counter transfer of units between the HKD counter and the RMB counter, the unitholders will only be able to trade their units in the relevant counter on the SEHK. The market price on the SEHK of units traded in HKD and of units traded in RMB may deviate significantly due to different factors, such as market liquidity, supply and demand in each counter and the exchange rate between the RMB and HKD (in both the onshore and the offshore markets). As such investors may pay more or receive less when buying units traded in HKD on the SEHK than in respect of units traded in RMB and vice versa. Investors without RMB accounts may buy and sell HKD traded units only. Such investors should note that distributions are made in RMB only and they may suffer a foreign exchange loss and incur foreign exchange associated fees and charges to receive their dividend. Not all brokers and CCASS participants may be familiar with and able to buy units in one counter and to sell units in the other or to carry out inter-counter transfers of units or to trade both counters at the same time. This may inhibit or delay an investor dealing in both HKD traded units and RMB traded units and may mean the investor can only trade in one currency.
  • As the SSE and the SZSE may be open when units in the Fund are not priced, the value of the securities in Fund’s portfolio may change on days when investors will not be able to purchase or sell the Fund’s units. Differences in trading hours between the SSE and the SZSE, and the SEHK and A-Shares’ trading bands may increase the level of premium/discount of the unit price to its NAV.
  • The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. A non-RMB based investors in units are exposed to foreign exchange risk. There is no guarantee that the value of RMB against the investors' base currencies (for example HKD) will not depreciate.
  • The Fund is not "actively managed" and therefore, when there is a decline in the Index, the Fund will also decrease in value. The Manager will not take defensive position in declining markets. Investors may lose a significant part or all of their respective investments if the Index falls.
  • Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC Asia High Dividend ETF
  • The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ Asia ex Japan Dividend Achievers Index.
  • The Fund primarily invests in high dividend yield securities in Asia. Such securities are subject to risks that the dividend could be reduced or abolished, or risks that the value of the securities could decline or have lower-than average potential for price appreciation.
  • The units of the Fund may trade at a substantial premium or discount to their NAV.
  • The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI Japan Hedged to USD ETF
  • The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI Japan 100% Hedged to USD Index.
  • The Fund concentrates its investment in Japanese securities and is subject to concentration risk as a result of tracking the performance of a single country (Japan). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Japan.
  • The Fund invests in currency forward contracts for hedging purposes. While this approach is designed to minimise the impact of currency fluctuations on the Fund’s returns, there are associated risks involved including costs of hedging, derivative and OTC transactions risks.
  • The units of the Fund may trade at a substantial premium or discount to their NAV.
  • The Fund is subject to tracking error risks due to factors such as fees and expenses, cost of hedging and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI Europe Quality Hedged to USD ETF
  • The fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI Europe Quality 100% Hedged to USD Index.
  • The Fund concentrates its investment in European securities and is subject to concentration risk as a result of tracking the performance of a single geographical region (Europe). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Europe.
  • The Fund invests in currency forward contracts for hedging purposes. While this approach is designed to minimise the impact of currency fluctuations on the Fund’s returns, there are associated risks involved including costs of hedging, derivative and OTC transactions risks.
  • The value of securities in the Fund’s portfolio may change on days when investors will not be able to purchase or sell units of the Fund as European stock exchanges will be open when units of the Fund are not priced.
  • The units of the Fund may trade at a substantial premium or discount to their NAV.
  • The Fund is subject to tracking error risks due to factors such as fees and expenses, cost of hedging and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC Hong Kong Banks ETF
  • The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ Hong Kong Banks Index. The Fund primarily invests in securities that are listed on The Stock Exchange of Hong Kong Limited and classified as Banks by the Industry Classification Benchmark (ICB).
  • The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (Hong Kong) and sector (banking). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Hong Kong and the banking sector. Stock prices of financial service companies are also more sensitive to the movement of interest rates.
  • The units of the Fund may trade at a substantial premium or discount to their NAV.
  • The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI Asia Pacific Real Estate ETF
  • The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI AC Asia Pacific Real Estate Index.
  • The Fund primarily invests in securities in the real estate sector in the Asia Pacific region, including real estate investment trusts (REITs). The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (Asia) and industry (real estate sector). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Asia and the real estate sector. There are risks associated with the real estate sector and REITs in particular.
  • Investing in emerging markets involves a greater risk of loss than investing in more developed markets due to, among other factors, greater political, tax, economic, foreign exchange, liquidity and regulatory risks.
  • The units of the Fund may trade at a substantial premium or discount to their NAV.
  • The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI China A Inclusion Index ETF
  • The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the MSCI China A Inclusion Index (the "Index"). The Fund invests in the PRC's securities market primarily through Stock Connect.
  • The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (the PRC) and may likely be more volatile than a broad-based fund.
  • Investing in PRC, an emerging market, involves a greater risk such as greater political, tax, economic, currency, liquidity, regulatory, legal, settlement and custody risks.
  • The Fund is subject to risks associated with the Stock Connect Programme, such as change of laws, rules and regulations, quota limitations and suspension of the Programme.
  • The Fund is subject to risks associated with the RQFII regime, such as change of laws, rules and regulations, insufficient RQFII quota, RQFII approval is revoked or terminated, or any of the key operators or parties is bankrupt or in default or disqualified.
  • If there is a suspension of the inter-counter transfer of units between the HKD and RMB counters and/or any limitation of services of brokers and CCASS participants, unitholders will only be able to trade their units in one counter only. The market price of units traded in each counter may deviate significantly. As such, investors may pay more or receive less when trading in HKD counter than in RMB counter and vice versa.
  • Unitholders will receive distributions in the RMB only. In the event that an unitholder has no RMB account, the unitholder may have to bear the bank or financial institution fees and charges associated with currency conversion.
  • As the stock exchanges in PRC may be open when units in the Fund are not priced, the value of the securities in the Fund's portfolio may change on days when investors will not be able to transact the Fund's Units.
  • Differences in trading hours between the SSE or the SZSE and the SEHK. A-Shares are subject to trading bands while units listed on the SEHK are not. Both factors may increase the level of premium or discount of the unit price to its NAV.
  • The Fund is not "actively managed" and therefore, when there is a decline in the Index, the Fund will also decrease in value. The Manager will not take defensive position in declining markets. Investors may lose a significant part or all of their respective investments if the Index falls.
  • The Index is a new index having only been launched on 23 October 2017. Given that the Index is relatively new, the Fund may be riskier than other ETF tracking more established indices.
  • Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important information about ChinaAMC Hang Seng Stock Connect Hong Kong SmallCap Index ETF
  • The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng Stock Connect Hong Kong SmallCap Index (the “Index”).
  • The underlying index of the Fund was changed to the present Index effective from 3 March 2017. During the rebalancing period from the previous index to the index, there is a risk that the tracking error and tracking difference of the Fund may increase.
  • The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region or country (the PRC including Hong Kong). The Fund may likely be more volatile than a broad-based fund.
  • The Fund invests in small cap securities. The stocks of small capitalisation companies may have lower liquidity and are typically more volatile and more vulnerable to adverse business or economic developments than those of larger capitalisation companies. Lower liquidity increases the risk that securities may be sold at a loss, and may impair the ability of the Fund to accurately track the Index.
  • Small capitalisation companies generally have less diverse product lines than large capitalisation companies and thus are more susceptible to adverse developments concerning their products, as well as the markets and sectors in which they operate. Small capitalisation companies may be less financially secure than larger and more established companies, and they are more vulnerable to loss of key personnel.
  • The Fund is not “actively managed” and therefore, when there is a decline in the Index, the Fund will also decrease in value. The Manager will not take defensive position in declining markets. Investors may lose a significant part or all of their respective investments if the Index falls.
  • Due to fees and expenses of the Fund, liquidity of the market and different investment strategies adopted by the Manager, the Fund’s return may deviate from that of the Index.
  • Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund’s NAV.

Important Information about ChinaAMC Asia USD Investment Grade Bond ETF
  • The fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the Bloomberg Barclays Asia USD Investment Grade Bond Index. The Fund primarily invests in fixed rate USD-denominated government-related and corporate investment grade bonds of the Asia ex-Japan region. Such investments involve special risks including interest rate risk, over-the-counter market risk, issuer risk, sovereign debt risk and illiquidity of bonds close to maturity risk.
  • Investing in emerging markets involves a greater risk of loss than investing in more developed markets due to, among other factors, greater political, tax, economic, foreign exchange, liquidity and regulatory risks.
  • The units of the Fund may trade at a substantial premium or discount to their NAV.
  • The Fund is subject to tracking error risks due to factors such as fees and expenses, the representative sampling strategy adopted by the Manager and the liquidity of the underlying bonds.
  • The Fund’s Base Currency is in HKD but has units traded in USD (in addition to HKD). Investors may be subject to additional costs or losses associated with foreign currency fluctuations between the Base Currency and the USD trading currency when trading units in the secondary market.
  • If there is a suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services provided by brokers and CCASS participants, unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing.
  • The market price of units traded in each counter may deviate significantly due to different factors such as market liquidity, market supply and demand in each counter and the exchange rate fluctuations between HKD and USD.

Important Information about ChinaAMC Bloomberg China Treasury + Policy Bank Bond Index ETF
  • The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Bloomberg China Treasury + Policy Bank Index (the “Index”).
  • The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (the PRC) and investing in bonds of a few issuers. The NAV of the Fund is likely to be more volatile than a broad-based fund.
  • Investments in the PRC may involve increased risks compared to more developed markets, such as liquidity risks, currency risks/control, political and economic uncertainties, legal and taxation risks, settlement risks and custody risk.
  • The Fund is subject to risks associated with Bond Connect and Foreign Access Regime, such as change of relevant rules and regulations, regulatory risks, volatility risk, liquidity risk, settlement and counterparty risk. The trading on the PRC interbank bond market or trading through Bond Connect may be suspended.
  • The Fund is subject to risk associated with debt securities, such as credit / counterparty risk, interest rate risk, volatility and liquidity risk, downgrade risk, sovereign debt risk, valuation risk, credit rating risk and credit agency risk.
  • The Fund is subject to risks relating to settlement procedures and default of counterparties on the PRC inter-bank bond market.
  • The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. The Fund has units traded in HKD and USD. Investors may be subject to additional costs or losses associated with foreign currency fluctuations.
  • The Fund may be subject to tracking error risk.
  • If any suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter only. The market price of units traded in each counter may deviate significantly.
  • The Fund is passively managed and the Manager will not have the discretion to adapt to market changes. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
  • Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC CSI 300 Index Daily (2x) Leveraged Product/ChinaAMC CSI 300 Index Daily (-1x) Inverse Product (The product is a synthetic product):
  • ChinaAMC CSI 300 Index Daily (2x) Leveraged Product/ChinaAMC CSI 300 Index Daily (-1x) Inverse Product (collectively, “Products”) are swaps-based leveraged/inverse products and are not suitable for all investors. The Products only target sophisticated trading-oriented investors who understand the potential consequences of seeking daily leveraged / inverse results and the associated risks and constantly monitor the performance of their holdings on a daily basis.
  • The Products seeks to obtain the required exposure through swaps with different swap counterparties. The Products aim to provide daily investment results, before fees and expenses, which closely correspond to the leveraged (2x) / inverse (-1x) daily performance of the CSI 300 Index (the “Index”).
  • The Products do not seek to achieve their stated investment objectives over a period of time greater than one day.
  • The Products are not intended for holding longer than one day as the performance of the Products over a longer period may deviate from and be uncorrelated to the leveraged/inverse performance of the Index over the period (e.g. the loss may be more than 2 times the decrease in the Index/-1 time the increase in the Index). The Products are designed to be used for short term trading or hedging purposes, and are not intended for long term investment.
  • Investing in the leveraged product is subject to the general market risk of equity investment, its value will be fluctuated because of multiple factors, and both gains and losses will be magnified. Investing in the inverse products is different from taking a short position. Because of daily rebalancing, the return profile of an inverse product is not the same as that of a short position. Risk investment outcomes of the inverse products are the opposite of conventional investment funds. If the value of the Index increases for extended periods, the inverse products will likely lose most or all of their values.
  • The Products also involve synthetic replication and counterparty risk, settlement risk, default risk, market risk, price movements risk, intraday counterparty risk, risk of increase in swap fees and early termination of swaps, derivative instrument investment risk, leveraged/inverse performance risk, risk of rebalancing activities, liquidity risk, intraday investment risk, currency risk, concentration risk, PRC market risk, risk of investment in debt securities and other funds, PRC tax risk, passive investment risk, trading risk, reliance on market maker risk, tracking error and correlation risk, volatility risk and termination risk.
  • Swap counterparties of the Products may have daily capacity limits, when the limits are reached, the Products' ability to adjust the size of swaps for sufficient exposure to achieve their investment objectives may be adversely affected.
ChinaAMC (HK) - Your first choice for trading Nasdaq The largest and the most comprehensive provider of Nasdaq-100 ETFs and Leveraged & Inverse ('L&I') Products in Hong Kong
Capturing Both the Up and Downside
of the US Tech Market
The data in the above chart is for illustration only and does not represent the actual performance in the future.
Source: Bloomberg as of August 2021, total return performance is calculated in USD from 12 February 2021 to 5 March 2021. Simulated performance is used for ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (7522 HK).
The data in the above chart is for illustration only and does not represent the actual performance in the future.
Source: Bloomberg as of August 2021, total return performance is calculated in USD from 13 May 2021 to 30 June 2021. Simulated performance is used for ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (7522 HK).
The data in the above chart is for illustration only and does not represent the actual performance in the future.
Source: Bloomberg as of August 2021, total return performance is calculated in USD from 22 July 2021 to 20 August 2021. Simulated performance is used for ChinaAMC NASDAQ-100 Index Daily (-2x) Inverse Product (7522 HK).
NASDAQ-100 Index
One of the world's preeminent technology indexes, reflecting the trend of tech stocks
NASDAQ-100 Index

The Index consists of 100 of the largest U.S. and international non-financial companies listed on The NASDAQ.

1. Representation of American Tech stocks
  • Constituent stocks are high-tech, high-growth and non-financial and serve as a valued representation of American tech stocks.
  • Internet companies weigh 24%, software companies weigh 18%, semiconductor companies weigh 14%
  • The major holdings include some largest tech giants, for example, Microsoft Corp., Amazon.Com Inc., Apple Inc., Facebook Inc. and Alphabet (Google), Tesla.
2. Higher Volatility
  • Nasdaq-100 index is relatively volatile comparing to other American Index.
  • Appealing for short-term strategical investments.
Source: Bloomberg, data as of 10 August 2021
NASDAQ-100 Index
Reasons for choosing ChinaAMC NASDAQ-100 Index ETF and Leveraged/Inverse Products
01
Comprehensive Nasdaq-100 Index ETF and Leveraged and Inverse Product Line

Provides comprehensive Nasdaq-100 Index ETF and Leveraged/Inverse Product Suites, ranging from physical ETF (3086 HK), leveraged (2x) (7261 HK), inverse (-1x) (7331 HK) to inverse (-2x) (7522 HK). This product series also allows trading in Asian time zones.

02
The first NASDAQ-100 Index Leveraged & Inverse Issuer in Hong Kong

ChinaAMC(HK) issued Asian's first two NASDAQ-100 Index daily (2x) leveraged and (-1x) inverse products in Hong Kong in 2016. ChinaAMC's name is made in the field and it has extensive managerial experience.

Leveraged and Inverse ('L&I') Products

About
Leveraged
and Inverse
(“L&I”) Products

Features

Daily
Rebalancing

Comparison with
other investment
products

ChinaAMC
Leveraged and
Inverse Product
Series

About Leveraged and Inverse (“L&I”) Products
About Leveraged and Inverse (“L&I”)Products

L&I Products are structured as Exchange Traded Funds (ETFs) and seek to achieve short-term investment results that correspond to the magnified or inverse performance of their underlying benchmarks on a daily basis.

Leveraged Products: Bullish for the Near Term

Seek to provide the leveraged (up to 2x) daily performance of their benchmark

Inverse Products: Bearish for the Near Term

Seek to provide the inverse (up to -2x) daily performance of their benchmark

Grasp your opportunity in a bull market. Leveraged Products seek to achieve a leveraged daily return (2x) of the benchmark's daily performance, before fees and expenses

Take hold of your opportunity in a bear market. Inverse Products seeks to achieve an inverse daily return (-1x)/(-2x) of the benchmark's daily performance, before fees and expenses

Leveraged Products seek to provide two times (2x) the daily performance of their benchmark

Seek to provide the Inverse (-1x) (up to 2x) daily performance of their benchmark

Seek to provide the inverse (-2x) daily performance of their benchmark

Take ChinaAMC NASDAQ-100 Index Daily (2X) Leveraged as an example. If the index goes up by 1%, the daily (2X) leveraged product will gain a daily return of 2%.

On the other hand, when the index drops by 1%, the daily (2X) leveraged product will have a daily loss of 2%.

Take ChinaAMC NASDAQ-100 Index daily (-1X) and (-2X) inverse as an example. When the index drops by 1%, the daily (-1X) inverse product will have a daily gain of 1% whereas the daily (-2X) inverse product will have a daily gain of 2%.

On the other hand, if the index goes up by 1%, the daily (-1X) inverse product will have a daily loss of 1%.

Note: For illustration only.

Note: For illustration only.

Features
Features
  • Seize opportunities in the short term, be it bull or bear.
  • Transparency: Intraday iNAV/IOPV available during trading hours
  • Leverage your daily return by 2 times on an uptrend
  • Helping to hedge against an expected decline
  • The products are listed on the Hong Kong Exchange, trading like stocks
  • No Hong Kong Stamp Duty on L&I Products
Daily Rebalancing

Leveraged and Inverse products will conduct daily adjustment at or around market close, to ensure the product can maintain the exposure ratio.

Daily Leveraged (2X) Products
If the index moves up, the product responds by increasing its exposure to the index
  • Hypothetical Example (Assuming the market goes up by 1%)
  • Product Asset

  • Total Exposure

Note: The above chart is for illustration of the products' investment strategy only
Daily Leveraged (2X) Products
If the index goes down, the product responds by decreasing its exposure to the index
  • Hypothetical Example (Assuming the market goes down by 1%)
  • Product Asset

  • Total Exposure

Note: The above chart is for illustration of the products' investment strategy only
Comparison with other investment products

Comparison of L&I Products and
Derivatives Warrants & Callable Bull / Bear Contracts (“CBBC”)

L&I products are not affected by expiration date, decay of time value, implied volatility and no Knock out feature

Leveraged and Inverse Product
Derivatives Warrants & CBBC
Trading method
Leveraged and Inverse ProductListed on exchanges, trade like stocks
Derivatives Warrants & CBBCListed on exchanges, trade like stocks
Gearing(X)
Leveraged and Inverse ProductDaily two times (2X), inverse one (-1X) or two times (-2X)
Derivatives Warrants & CBBC5 to 40 times, affected by different factors
Maturity
Leveraged and Inverse ProductNO
Derivatives Warrants & CBBCYES
Time Decay
Leveraged and Inverse ProductNO
Derivatives Warrants & CBBCYES
Implied Volatility
Leveraged and Inverse ProductNO
Derivatives Warrants & CBBCYES(Derivatives Warrants)
Mandatory call feature
Leveraged and Inverse ProductNO
Derivatives Warrants & CBBCYES (CBBC)
Liquidity Providers
Leveraged and Inverse ProductIndependent participating dealers to maintain liquidity
Derivatives Warrants & CBBCIssuer being the liquidity provider
Pricing Transparency
Leveraged and Inverse ProductHigher: NAV as pricing reference
Derivatives Warrants & CBBCRelatively low: issuers, as the liquidity provider, may have impact on derivative warrant price
Pricing Reference
Leveraged and Inverse ProductIndex level, daily rebalancing
Derivatives Warrants & CBBCIndex level, implied volatility, time decay of value, interest rate
Issuer Default Risk
Leveraged and Inverse ProductLower: assets (cash & futures) are independently stored on third party custodian account (HSBC Custodian Bank)
Derivatives Warrants & CBBCInvestors bear the issuer default risk

Comparison of L&I Products and Margin Trading

Loss of L&I products is limited to the amount invested and the positions would not be liquidated if the market moves against your position

Leveraged and Inverse Products
Futures and Margin Products
Minimum investment requirement
Leveraged and Inverse ProductsAround HKD 800
Futures and Margin ProductsAround HKD 120,000 (Assume 10% margin requirement for one Hang Seng Index futures contract)
Will the loss exceed the amount invested?
Leveraged and Inverse ProductsNO
Futures and Margin ProductsYES
Margin Account needed?
Leveraged and Inverse ProductsNO
Futures and Margin ProductsYES
Need to maintain maintenance margin?
Leveraged and Inverse ProductsNO
Futures and Margin ProductsDaily
Will positions be liquidated?
Leveraged and Inverse ProductsNO
Futures and Margin ProductsYES
Position Management : Need to rollover the contract?
Leveraged and Inverse ProductsNO
Futures and Margin ProductsInvestors need to roll over futures contract, pay trading fee as well as adjust the collateral value to maintain the position
Will investors be requested to inject extra capital to maintain the margin?
Leveraged and Inverse ProductsNO
Futures and Margin ProductsYES
ChinaAMC Leveraged and Inverse Product Series